tirzepatide a FDA Grants New Indication for Obesity Management Tirzepatide for diabetes: on track

While short-term efficacy is well-documented, concerns remain about the long-term impact of prolonged GLP-1 receptor activation, particularly in non-diabetic populations

In contrast, the market favors tyrosinase inhibitors with lower toxicity, including natural products like arbutin, peptides, and Chinese medicinal extracts

The doublespeak triggered some backlashnot only because the company is, in fact, capitalizing on the $15 billion weight-loss drug market, but because the company also didnt explicitly mention in the voiceover that it sells the compounded version of these medications (made by combining, mixing, or altering ingredients), which arent approved by the FDA

Antihistamines are a common solution

Comprehensive Initial Evaluation: The tailoring process begins with an in-depth consultation

*Individual experiences vary